Late Breaking Abstract - A single centre observational study of inflammatory biomarkers in Covid 19 and clinically important outcomes

I. Sau (Wolverhampton, United Kingdom), E. Qureshi (Wolverhampton, United Kingdom), D. Mears (Wolverhampton, United Kingdom), S. Ejiofor (Wolverhampton, United Kingdom)

Source: Virtual Congress 2021 – Back to infection basics
Session: Back to infection basics
Session type: E-poster
Number: 2366

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Sau (Wolverhampton, United Kingdom), E. Qureshi (Wolverhampton, United Kingdom), D. Mears (Wolverhampton, United Kingdom), S. Ejiofor (Wolverhampton, United Kingdom). Late Breaking Abstract - A single centre observational study of inflammatory biomarkers in Covid 19 and clinically important outcomes. 2366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study.
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Late Breaking Abstract - Identification of obstructive lung disease in Austrian pharmacies - a multi-site, cross-sectional case finding study
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Late Breaking Abstract - Tocilizumab in hospitalized patients with severe COVID-19: an open label, prospective study
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017


Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018



Predicting factors for sarcoidosis outcome: retrospective cohort study
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020


Late Breaking Abstract - Nationwide asthma management and disease control in primary versus secondary care – a real-world evidence study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study
Source: Eur Respir J, 56 (6) 2003498; 10.1183/13993003.03498-2020
Year: 2020



Late Breaking Abstract - Burden of disease, diagnostic work-up and management of bronchiectasis in outpatient clinics – a five-year prospective cohort study
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019

Late Breaking Abstract - Dietary patterns and lung function in a case-control study of asthma in Italian adults.
Source: International Congress 2019 – More and more COPD
Year: 2019